Coronary Disease Clinical Trials
Myocardial Ischemia and Transfusion (MINT)
The purpose of this study is to assess among patients with an acute myocardial infarction and a hemoglobin concentration less than 10 g/dL, if a liberal transfusion strategy with a threshold of 10 g/dL reduces the rate of the composite outcome of all-cause mortality or recurrent nonfatal acute myocardial infarction through 30 days following randomization compared to a restrictive transfusion strategy with a threshold of 7 to 8 g/dL.
Primary Investigator: Michael Gitter, MD
Subinvestigators: Matthew Karafin, MD; Nicole Lohr, MD, PhD; David S. Marks, MD, MBA
Status: Currently enrolling
Sub Category: General Cardiology